Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 and Cancer: a Comprehensive Review
Rohit Gosain, Yara Abdou, Abhay Singh, et al.
Current Oncology Reports (2020) Vol. 22, Iss. 5
Open Access | Times Cited: 290

Showing 1-25 of 290 citing articles:

COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Masataka Nishiga, Dao Wen Wang, Yaling Han, et al.
Nature Reviews Cardiology (2020) Vol. 17, Iss. 9, pp. 543-558
Open Access | Times Cited: 1303
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
Michael Dougan, Ajay Nirula, Masoud Azizad, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 15, pp. 1382-1392
Open Access | Times Cited: 405
Phage Display Derived Monoclonal Antibodies: From Bench to Bedside
Mohamed A. Alfaleh, Hashem O. Alsaab, Ahmad Bakur Mahmoud, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 211
COVID-19 vaccination for people with severe mental illness: why, what, and how?
Victor Mazereel, Kristof Van Assche, Johan Detraux, et al.
The Lancet Psychiatry (2021) Vol. 8, Iss. 5, pp. 444-450
Open Access | Times Cited: 146
European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer
Greta Carioli, Matteo Malvezzi, Paola Bertuccio, et al.
Annals of Oncology (2021) Vol. 32, Iss. 4, pp. 478-487
Open Access | Times Cited: 140
Circulating microRNAs: Biomarkers of disease
Yudong Wu, Qian Li, Renshuai Zhang, et al.
Clinica Chimica Acta (2021) Vol. 516, pp. 46-54
Closed Access | Times Cited: 121
European cancer mortality predictions for the year 2022 with focus on ovarian cancer
Michela Dalmartello, Carlo La Vecchia, Paola Bertuccio, et al.
Annals of Oncology (2022) Vol. 33, Iss. 3, pp. 330-339
Open Access | Times Cited: 107
COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnology
Hyun Jee Han, Chinekwu Sherridan Nwagwu, Obumneme Benneth Anyim, et al.
International Immunopharmacology (2020) Vol. 90, pp. 107247-107247
Open Access | Times Cited: 119
Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019
Ravindra Ganesh, Lindsey M. Philpot, Dennis M. Bierle, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 8, pp. 1278-1286
Open Access | Times Cited: 97
How does COVID-19 fear and anxiety affect chemotherapy adherence in patients with cancer
Cengiz Karaçin, İrem Bilgetekin, Fatma Buğdaycı Başal, et al.
Future Oncology (2020) Vol. 16, Iss. 29, pp. 2283-2293
Open Access | Times Cited: 86
Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?
Hunter B. Moore, Christopher D. Barrett, Ernest E. Moore, et al.
Journal of Trauma and Acute Care Surgery (2020) Vol. 88, Iss. 6, pp. 713-714
Open Access | Times Cited: 84
Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients
Romain Palich, Marianne Veyri, Stéphane Marot, et al.
Annals of Oncology (2021) Vol. 32, Iss. 8, pp. 1051-1053
Open Access | Times Cited: 79
Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study
Karlijn de Joode, Daphne W. Dumoulin, Jolien Tol, et al.
European Journal of Cancer (2020) Vol. 141, pp. 171-184
Open Access | Times Cited: 73
Clinical outcomes and risk factors for severe COVID‐19 in patients with haematological disorders receiving chemo‐ or immunotherapy
Thomas A. Fox, Ethan Troy‐Barnes, Amy A. Kirkwood, et al.
British Journal of Haematology (2020) Vol. 191, Iss. 2, pp. 194-206
Open Access | Times Cited: 71
Perceived changes of specific attitudes, perceptions and behaviors during the Corona pandemic and their relation to wellbeing
Arndt Büssing, Daniela Rodrigues Recchia, Rudolf Hein, et al.
Health and Quality of Life Outcomes (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 70
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area
Giuliana Amaddeo, Raffaele Brustia, Manon Allaire, et al.
JHEP Reports (2020) Vol. 3, Iss. 1, pp. 100199-100199
Open Access | Times Cited: 69
Recent advances in catalytic hairpin assembly signal amplification-based sensing strategies for microRNA detection
Yan Wu, Cuicui Fu, Wenbing Shi, et al.
Talanta (2021) Vol. 235, pp. 122735-122735
Closed Access | Times Cited: 67
Endothelial cells and SARS-CoV-2: An intimate relationship
Lucas Cunha Barbosa, Thaynan Lopes Gonçalves, Luanna Prudencio de Araújo, et al.
Vascular Pharmacology (2021) Vol. 137, pp. 106829-106829
Open Access | Times Cited: 66
RNA–RNA interactions between SARS-CoV-2 and host benefit viral development and evolution during COVID-19 infection
Song Zhang, Kuerbannisha Amahong, Chenyang Zhang, et al.
Briefings in Bioinformatics (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 55
New progresses on cell surface protein HSPA5/BiP/GRP78 in cancers and COVID-19
Ting Li, Jiewen Fu, Jingliang Cheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
Cancer has not gone away: A primary care perspective to support a balanced approach for timely cancer diagnosis during COVID‐19
Charles W. Helsper, Christine Campbell, Jon Emery, et al.
European Journal of Cancer Care (2020) Vol. 29, Iss. 5
Open Access | Times Cited: 66
COVID-19: Implications for People with Chagas Disease
Ezequiel Zaidel, Colin Forsyth, Gabriel Novick, et al.
Global Heart (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 65
Withaferin A: a potential therapeutic agent against COVID-19 infection
Alex R. Straughn, Sham S. Kakar
Journal of Ovarian Research (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 57
The common risk factors for progression and mortality in COVID-19 patients: a meta-analysis
Li Zhang, Jie Hou, Fu-Zhe Ma, et al.
Archives of Virology (2021)
Open Access | Times Cited: 52
Potential Effects of Coronaviruses on the Liver: An Update
Xinyi Wang, Jianyong Lei, Zhihui Li, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 52
Page 1 - Next Page

Scroll to top